Possible Side Effects | Aimovig (erenumab-aooe)
close
  • Approved Use: Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.

What are the possible side effects of Aimovig?

Everybody’s experience with Aimovig is different. It’s important to talk to your doctor about whether Aimovig is right for you, and to learn about its possible side effects.

You shouldn’t take Aimovig if you’re allergic to erenumab-aooe or any of the ingredients in Aimovig. Allergic reactions like rash or swelling can happen hours to days after taking Aimovig.

Aimovig was studied in three clinical trials of approximately 2,100 patients.

Side effects seen in at least 2% of patients on Aimovig and at least 2% more common than those on placebo
Side effects in the first 3 months Side effects in the first 3 months

*Injection site reactions include multiple adverse reactions described with related terms, such as injection site pain and injection site redness.

The rate of injection site reactions reported in this figure is with the prefilled syringe.

In clinical studies, the most common injection site reactions were pain, redness, and swelling.

pie chart pie chart

Common side effects observed were injection site reactions, constipation, and cramps with muscle spasms.

Aimovig may cause serious side effects, including allergic reactions, high blood pressure, and constipation with serious complications.

These are not all of the possible side effects of Aimovig. Ask your pharmacist or doctor for more information. Call your doctor for medical advice about side effects. You may report side effects to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088. You may also report side effects to Amgen at 1-800-77-AMGEN (1-800-772-6436).

Please see below for additional Important Safety Information.

+ +

Important Safety Information

Who should not use Aimovig®?
Do not use Aimovig if you are allergic to erenumab-aooe or any ingredients in

Who should not use Aimovig? Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®. Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

 

Important Safety Information

Who should not use Aimovig®? Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®. Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed. Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements. What are possible side effects of Aimovig®? Aimovig® may cause serious side effects, including:
  • Allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig®. This can happen within hours to days after using Aimovig®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue or throat, or trouble breathing.
  • Constipation with serious complications. Severe constipation can happen after receiving Aimovig®. In some cases people have been hospitalized or needed surgery. Contact your HCP if you have severe constipation.
  • High blood pressure. High blood pressure or worsening of high blood pressure can happen after receiving Aimovig®. Contact your healthcare provider if you have an increase in blood pressure.
The most common side effects of Aimovig® are pain, redness, or swelling at the injection site and constipation. These are not all of the possible side effects of Aimovig®. Call your HCP for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088. Click here for the full Prescribing Information and Patient Product Information.

Approved Use

Aimovig® is a prescription medicine used for the preventive treatment of migraine in adults.
References: 1. Parsabiv® (etelcalcetide) prescribing information, Amgen. 2. Data on file, Amgen; [Summary of Clinical Efficacy; 2015]. 3. Alexander ST, et al. Mol Pharmacol. 2015;88:853-865. 4. Data on file, Amgen; [Report R20130052, 2014]. 5. Chen P, et al. CPT Pharmacometrics Syst Pharmacol. 2016;5:484-494. 6. Sensipar® (cinacalcet) prescribing information, Amgen. 7. Ma JN, et al. J Pharmacol Exp Ther. 2011;337:275-284.